West Pharma (WST) Tops Q4 EPS by 10c, Revenues Beat; Initiates FY20 EPS/Revenue Mid-Point Guidance Above Consensus
Go back to West Pharma (WST) Tops Q4 EPS by 10c, Revenues Beat; Initiates FY20 EPS/Revenue Mid-Point Guidance Above Consensus| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 336.24 +6.53 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $329.71 | 52 Week High | $84.33 | |||
| Open | $328.45 | 52 Week Low | $53.88 | |||
| Day High | $336.26 | P/E | 214.17 | |||
| Day Low | $327.61 | EPS | $1.57 | |||
| Volume | 423,157 | |||||
